Thus, considering the large inter-patient variability for midostaurin plasma concentration and the marginal free concentration relative to the IC50 value, it was not surprising that the results showed an inconsistent and variable inhibition of PKC activity in melanoma deposits in vivo. Here, PRRT2 is linked to melanoma.